title: In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
abstract: We report a system for generating infectious papillomaviruses in vitro that facilitates the analysis of papillomavirus assembly, infectivity, and serologic relatedness. Cultured hamster BPHE-1 cells harboring autonomously replicating bovine papillomavirus type 1 (BPV1) genomes were infected with recombinant Semliki Forest viruses that express the structural proteins of BPV1. When plated on C127 cells, extracts from cells expressing L1 and L2 together induced numerous transformed foci that could be specifically prevented by BPV neutralizing antibodies, demonstrating that BPV infection was responsible for the focal transformation. Extracts from BPHE-1 cells expressing L1 or L2 separately were not infectious. Although Semliki Forest virus-expressed L1 self-assembled into virus-like particles (VLPs), viral DNA was detected in particles only when L2 was coexpressed with L1, indicating that genome encapsidation requires L2. Expression of human papillomavirus type 16 (HPV16) L1 and L2 together in BPHE-1 cells also yielded infectious virus. These pseudotyped virions were neutralized by antiserum to HPV16 VLPs derived from European (114/K) or African (Z-1194) HPV16 variants but not by antisera to BPV VLPs, to a poorly assembling mutant HPV16 L1 protein, or to VLPs of closely related genital HPV types. Extracts from BPHE-1 cells coexpressing BPV L1 and HPV16 L2 or HPV16 L1 and BPV L2 were not infectious. We conclude that (i) mouse C127 cells express the cell surface receptor for HPV16 and are able to uncoat HPV16 capsids; (ii) if a papillomavirus DNA packaging signal exists, then it is conserved between the BPV and HPV16 genomes; (iii) functional L1-L2 interaction exhibits type specificity; and (iv) protection by HPV virus-like particle vaccines is likely to be type specific.
authors.affiliation: Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Roden
authors.forename: H L
authors.initials: HL
authors.lastname: Greenstone
authors.forename: R
authors.initials: R
authors.lastname: Kirnbauer
authors.forename: F P
authors.initials: FP
authors.lastname: Booy
authors.forename: J
authors.initials: J
authors.lastname: Jessie
authors.forename: D R
authors.initials: DR
authors.lastname: Lowy
authors.forename: J T
authors.initials: JT
authors.lastname: Schiller
mesh_terms: D000818:Animals; D001483:Base Sequence; D052688:Bovine papillomavirus 1 / Q000235:genetics / Q000502:physiology* / Q000648:ultrastructure; D002213:Capsid / Q000096:biosynthesis; D002417:Cattle; D002460:Cell Line; D002472:Cell Transformation, Viral; D006224:Cricetinae; D017931:DNA Primers; D004261:DNA Replication; D016679:Genome, Viral; D006801:Humans; D007668:Kidney; D051379:Mice; D008969:Molecular Sequence Data; D027383:Papillomaviridae / Q000235:genetics / Q000502:physiology* / Q000648:ultrastructure; D016133:Polymerase Chain Reaction; D012672:Semliki forest virus / Q000235:genetics / Q000502:physiology / Q000648:ultrastructure; D015678:Viral Structural Proteins / Q000096:biosynthesis*; D014771:Virion / Q000502:physiology; D014779:Virus Replication
chemical_list: D017931:DNA Primers; D015678:Viral Structural Proteins